This is a routine personnel announcement with no financial data or material business changes. No trading action warranted — monitor next quarterly filing for any operational improvement metrics at MDC.
Price Chart
Executive Summary
Integrated BioPharma's wholly-owned subsidiary Manhattan Drug Company appointed Michael Richtmyer as Head of Operations, effective August 3, 2026. This is a routine senior operations hire for a contract manufacturing subsidiary with no financial terms disclosed — a non-material operational change that does not move the stock.
Key Facts
- Michael Richtmyer appointed Head of Operations at Manhattan Drug Company, effective August 3, 2026
- Richtmyer brings 35+ years of experience in pharmaceutical/nutraceutical contract manufacturing
- He previously worked at the company from 1991 to 1999
- Most recently served as President of Tishcon Corp., managing two manufacturing sites with 650+ active products
- No financial terms, compensation, or performance targets disclosed in the filing
Financial Impact
No financial impact disclosed — routine operational hire with no material financial terms
Risk Factors
- No material risks disclosed in this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-028628 |
| Exhibit: ex_1007671.htm | 0001437749-26-028628 |
| Document: 0001437749-26-028628-index-headers.html | 0001437749-26-028628 |
| Document: 0001437749-26-028628-index.html | 0001437749-26-028628 |
| Document: 0001437749-26-028628.txt | 0001437749-26-028628 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 25, 2026 4w ago | 8-K | $0.1700 $0.1800 | ▼ −5.88% | ▼ −5.91% | $0.1700 (−0.00%) |
Aug 20, 2026 9w ago | 8-K | $0.1800 $0.1700 | ▼ −5.56% | ▼ −5.56% | $0.1700 (−5.56%) |
Jul 2, 2026 16w ago | 8-K | $0.1800 $0.1600 | ▼ −11.11% | ▼ −10.70% | $0.1700 (−5.56%) |
May 8, 2026 24w ago | 8-K | $0.2500 $0.1800 | ▲ +28.00% | ▲ +27.70% | $0.1700 (+32.00%) |
Apr 15, 2026 27w ago | 8-K | $0.2800 $0.2500 | ▼ −10.71% | ▼ −16.76% | $0.1700 (−39.29%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers